Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer

American Journal of Surgery

Volumn 188, Issue 3, 2004, Pages 261-266

  Nakamura, Tsutomu ^a   Hayashi, Kazuhiko ^a   Ota, Masaho ^a   Eguchi, Reiki ^a   Ide, Hiroko ^a   Takasaki, Ken ^a   Mitsuhashi, Norio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Definitive chemoradiotherapy; Esophageal cancer; Neoadjuvant chemoradiotherapy; Salvage esophagectomy; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SURGICAL RISK; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 4644295803     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2004.06.003     Document Type: Article

References (31)

1. Ando N., Ozawa S., Kitagawa Y., et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 232:2000;225-232
2. Hofstetter W., Swisher S.G., Correa A.M., et al. Treatment outcome of resected esophageal cancer. Ann Surg. 236:2002;376-385
3. Franklin R., Steiger Z., Vaishampayan G., et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer. 51:1983;1062-1071
4. Jones D.R., Detterbeck F.C., Egan T.M., et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg. 64:1997;185-192
5. Posner M.C., Gooding W.E., Lew J.I., et al. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Surgery. 130:2001;620-628
6. Vogel S.B., Mendenhall W., Sombeck M.D., et al. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 221:1995;685-695
7. Yano M., Tsujinaka T., Shiozaki H., et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol. 70:1999;25-32
8. Slater M.S., Holland J., Faigel D.O., et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg. 181:2001;440-444
9. Ohtsu A., Boku N., Muro K., et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 17:1999;2915-2921
10. Nishimura Y., Suzuki M., Nakamatsu K., et al. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys. 53:2002;134-139
11. De Pree C., Aapro M.S., Spiliopoulos A., et al. Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol. 6:1995;551-557
12. Burmeister B.H., Denham J.W., O'Brien M., et al. Combined modality therapy for esophageal carcinoma preliminary results from a large Australasian multicenter study. Int J Radiat Oncol Biol Phys. 32:1995;997-1006
13. Coia L.R., Berkey B.A., John M.J., et al. Outcome of patients receiving radiation for cancer of the esophagus results of the 1992-1994 patterns of care study. J Clin Oncol. 18:2000;455-462
14. Kavanagh B., Anscher M., Leopold K., et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys. 24:1992;633-642
15. Gill P.G., Denham J.W., Jamieson G.G., et al. Pattern of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment followed by surgery. J Clin Oncol. 10:1992;1037-1043
16. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 337:1997;161-167
17. Le Price E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer. 73:1994;1779-1784
18. Liedman B., Johnsson E., Merke C., et al. Preoperative adjuvant radiochemotherapy may increase the risk in patients undergoing thoracoabdominal esophageal resections. Dig Surg. 18:2001;169-175
19. Eguchi R., Ide H., Nakamura T., et al. Analysis of postoperative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy. Jpn J Thorac Cardiovasc Surg. 47:1999;552-558
20. Swisher S.G., Wynn P., Putnam J.B., et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg. 123:2002;175-183
21. Sobin L.H., Wittekid C. TNM Classification of Malignant Tumors International Union Against Cancer. 5th ed :1997;Wiley, New York, NY
22. Japanese Society for Esophageal Diseases. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 9th English ed :2001;Kanehara, Tokyo, Japan
23. Adelstein D.J., Rice T.W., Rybicki L.A., et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol. 18:2000;2032-2039
24. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Group 94-05) phase III trial of combined-modality therapy for esophageal cancer high-dose versus standard-dose radiation therapy. J Clin Oncol. 20:2002;1167-1174
25. Movsas B., Raffin T.A., Epstein A.H., Link C.J. Jr. Pulmonary radiation injury. Chest. 111:1997;1061-1076
26. Riedel M., Stein H.J., Mounyam L., et al. Influence of simultaneous neoadjuvant radiotherapy and chemotherapy on bronchoscopic findings and lung function in patients with locally advanced proximal esophageal cancer. Am J Respir Crit Care Med. 162:2000;1741-1746
27. Nagawa H., Kobori O., Muto T. Prediction of pulmonary complications after oesophagectomy. Br J Surg. 81:1994;860-862
28. Law S.Y.K., Fok M., Wong J. Risk analysis of squamous cell carcinoma of the esophagus. World J Surg. 18:1994;339-346
29. Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 236;2:184-90
30. Adelstein D.J., Rice T.W., Becker M., et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer. 80:1997;1011-1020
31. Brücher B.L.D.M., Weber W., Bauer M., et al. Neoadjuvant therapy of esophageal squamous cell carcinoma response evaluation by positron emission tomography. Ann Surg. 233:2001;300-309